Filteren op Last updated date SelecterenNaVoorFrom - To Datum Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Laat dit veld leeg Filter Resultaten (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues 31 maart 2021 News Human COVID-19 Vaccines EU recommendations for 2021-2022 seasonal flu vaccine composition 30 maart 2021 News Human Medicines Vaccines EMA working on COVID-19 over holiday period 30 maart 2021 News Corporate COVID-19 Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna 26 maart 2021 News Human COVID-19 Vaccines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 March 2021 26 maart 2021 News Human COVID-19 Generic and hybrid medicines Medicines Referrals EMA issues advice on use of regdanvimab for treating COVID-19 26 maart 2021 News Human COVID-19 Medicines COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases 25 maart 2021 News Human COVID-19 Vaccines EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials 22 maart 2021 News Human COVID-19 Medicines Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-18 March 2021 19 maart 2021 News Veterinary Medicines COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets 19 maart 2021 News Human COVID-19 Vaccines 1 … 63 64 65 66 67 Page 67 of 379 68 69 70 71 … 379
AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues 31 maart 2021 News Human COVID-19 Vaccines
EU recommendations for 2021-2022 seasonal flu vaccine composition 30 maart 2021 News Human Medicines Vaccines
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna 26 maart 2021 News Human COVID-19 Vaccines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 March 2021 26 maart 2021 News Human COVID-19 Generic and hybrid medicines Medicines Referrals
EMA issues advice on use of regdanvimab for treating COVID-19 26 maart 2021 News Human COVID-19 Medicines
COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases 25 maart 2021 News Human COVID-19 Vaccines
EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials 22 maart 2021 News Human COVID-19 Medicines
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-18 March 2021 19 maart 2021 News Veterinary Medicines
COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets 19 maart 2021 News Human COVID-19 Vaccines